Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology SJ Forrester, GW Booz, CD Sigmund, TM Coffman, T Kawai, V Rizzo, ... Physiological reviews 98 (3), 1627-1738, 2018 | 893 | 2018 |
Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system KM Baker, GW Booz, DE Dostal Annual review of physiology 54 (1), 227-241, 1992 | 667 | 1992 |
Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. W Schorb, GW Booz, DE Dostal, KM Conrad, KC Chang, KM Baker Circulation research 72 (6), 1245-1254, 1993 | 464 | 1993 |
Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts GW Booz, KM Baker Cardiovascular research 30 (4), 537-543, 1995 | 362 | 1995 |
Role of type 1 and type 2 angiotensin receptors in angiotensin II–induced cardiomyocyte hypertrophy GW Booz, KM Baker Hypertension 28 (4), 635-640, 1996 | 329 | 1996 |
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress GW Booz Free Radical Biology and Medicine 51 (5), 1054-1061, 2011 | 311 | 2011 |
Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets W Lv, GW Booz, Y Wang, F Fan, RJ Roman European journal of pharmacology 820, 65-76, 2018 | 272 | 2018 |
Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure GW Booz, JNE Day, KM Baker Journal of molecular and cellular cardiology 34 (11), 1443-1453, 2002 | 235 | 2002 |
Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy KM Baker, MI Chernin, T Schreiber, S Sanghi, S Haiderzaidi, GW Booz, ... Regulatory peptides 120 (1-3), 5-13, 2004 | 190 | 2004 |
Angiotensin-II-binding sites on hepatocyte nuclei. GW Booz, KM Conrad, AL Hess, HA Singer, KM Baker Endocrinology 130 (6), 3641-3649, 1992 | 188 | 1992 |
Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: an autocrine loop for hypertrophy J Fukuzawa, GW Booz, RA Hunt, N Shimizu, V Karoor, KM Baker, ... Hypertension 35 (6), 1191-1196, 2000 | 162 | 2000 |
High‐fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT 3 loss H Zeng, VR Vaka, X He, GW Booz, JX Chen Journal of cellular and molecular medicine 19 (8), 1847-1856, 2015 | 148 | 2015 |
Oxidative stress and renal fibrosis: recent insights for the development of novel therapeutic strategies W Lv, GW Booz, F Fan, Y Wang, RJ Roman Frontiers in physiology 9, 105, 2018 | 138 | 2018 |
Conflicting vascular and metabolic impact of the IL-33/sST2 axis R Altara, R Ghali, Z Mallat, A Cataliotti, GW Booz, FA Zouein Cardiovascular research 114 (12), 1578-1594, 2018 | 123 | 2018 |
New take on the role of angiotensin II in cardiac hypertrophy and fibrosis M Kurdi, GW Booz Hypertension 57 (6), 1034-1038, 2011 | 122 | 2011 |
Angiotensin II signalling pathways in cardiac fibroblasts: conventional versus novel mechanisms in mediating cardiac growth and function DE Dostal, GW Booz, KM Baker Molecular and cellular biochemistry 157 (1), 15-21, 1996 | 121 | 1996 |
Involvement of protein kianse C and Ca2+ in angiotensin II-induced mitogenesis of cardiac fibroblasts GW Booz, DE Dostal, HA Singer, KM Baker American Journal of Physiology-Cell Physiology 267 (5), C1308-C1318, 1994 | 119 | 1994 |
Working outside the system: an update on the unconventional behavior of the renin–angiotensin system components M Kurdi, WC De Mello, GW Booz The international journal of biochemistry & cell biology 37 (7), 1357-1367, 2005 | 113 | 2005 |
Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches S Shekhar, MW Cunningham, MR Pabbidi, S Wang, GW Booz, F Fan European journal of pharmacology 833, 531-544, 2018 | 111 | 2018 |
Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects A Kaplan, E Abidi, A El-Yazbi, A Eid, GW Booz, FA Zouein Heart Failure Reviews 23, 419-437, 2018 | 111 | 2018 |